Copy number alterations of VGLL3 and YAP1 have been reported for human soft tissue sarcomas including rhabdomoysarcomas, where VGLL3 is required for proliferation (Cancer Genome Atlas Research Network, 2017; Hélias-Rodzewicz et al., 2010). Here, VGLL3 is linked to soft tissue sarcoma.